Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair and restore hearing. Founded by Gabriel Corfas and M. Charles Liberman in 2015, Decibel Therapeutics is backed by investors that include Sobrato Capital, BlackRock, Bessemer Venture Partners, OrbiMed, and GV and is headquartered in Cambridge.